↓ Skip to main content

Bevacizumab Eye Drops Vs. Intra-meibomian Gland Injection of Bevacizumab for Meibomian Gland Dysfunction-Associated Posterior Blepharitis

Overview of attention for article published in Frontiers in Medicine, June 2022
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bevacizumab Eye Drops Vs. Intra-meibomian Gland Injection of Bevacizumab for Meibomian Gland Dysfunction-Associated Posterior Blepharitis
Published in
Frontiers in Medicine, June 2022
DOI 10.3389/fmed.2022.895418
Pubmed ID
Authors

Chitchanok Tantipat, Ngamjit Kasetsuwan, Patraramon Chotikkakamthorn, Krit Pongpirul

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 8%
Lecturer 1 8%
Other 1 8%
Student > Doctoral Student 1 8%
Unknown 9 69%
Readers by discipline Count As %
Medicine and Dentistry 3 23%
Psychology 1 8%
Unknown 9 69%